Polyubiquitin binding and cross-reactivity in the USP domain deubiquitinase USP21
Modification of proteins by ubiquitin (Ub) and Ub‐like (Ubl) modifiers regulates a variety of cellular functions. The ability of Ub to form chains of eight structurally and functionally distinct types adds further complexity to the system. Ub‐specific proteases (USPs) hydrolyse polyUb chains, and so...
Saved in:
Published in: | EMBO reports Vol. 12; no. 4; pp. 350 - 357 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Chichester, UK
John Wiley & Sons, Ltd
01-04-2011
Nature Publishing Group UK Blackwell Publishing Ltd Nature Publishing Group |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Modification of proteins by ubiquitin (Ub) and Ub‐like (Ubl) modifiers regulates a variety of cellular functions. The ability of Ub to form chains of eight structurally and functionally distinct types adds further complexity to the system. Ub‐specific proteases (USPs) hydrolyse polyUb chains, and some have been suggested to be cross‐reactive with Ubl modifiers, such as neural precursor cell expressed, developmentally downregulated 8 (NEDD8) and interferon‐stimulated gene 15 (ISG15). Here, we report that USP21 cleaves Ub polymers, and with reduced activity also targets ISG15, but is inactive against NEDD8. A crystal structure of USP21 in complex with linear diUb aldehyde shows how USP21 interacts with polyUb through a previously unidentified second Ub‐ and ISG15‐binding surface on the USP domain core. We also rationalize the inability of USP21 to target NEDD8 and identify differences that allow USPs to distinguish between structurally related modifications.
The crystal structure of the ubiquitin‐specific protease USP21 bound to linear diubiquitin‐aldehyde reveals a second S2 ubiquitin/ISG15‐binding site. The structure reveals why USP21 cannot hydrolyze NEDD8 modifications. |
---|---|
Bibliography: | Supplementary Material ArticleID:EMBR201117 ark:/67375/WNG-F7NL70C8-3 istex:1B9431FD72ABB8B9706263A96DA82C1258BA18DC Present address: Laboratory of Biochemistry and Molecular Biology, NCI, National Institutes of Health, Bethesda, Maryland 20892, USA Present address: Institute of Biochemistry, ETH Hönggerberg HPM G10, CH‐8093 Zürich, Switzerland ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Present address: Institute of Biochemistry, ETH Hönggerberg HPM G10, CH-8093 Zürich, Switzerland |
ISSN: | 1469-221X 1469-3178 |
DOI: | 10.1038/embor.2011.17 |